Ms. Wipperman Heine currently serves as an independent member of the Board of Directors of Surmodics, Inc. (NASDAQ: SRDX), Natus Medical (NASDAQ: NTUS), Miromatrix (NASDAQ: MIRO) and privately held Gradient Denervation Technologies.

Previously, Ms. Heine was President and Chief Executive Officer at preCARDIA, Inc., an early stage, heart failure focused medtech company which was acquired by Abiomed, Inc. in 2021. From 2015 to 2019, she was Chief Operating Officer at Mitralign, Inc., a venture backed medtech company focused on transcatheter heart valve annuloplasty. Prior to Mitralign, Ms. Heine was Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption.

Ms. Heine has also served in multiple leadership roles at ev3 and Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Ms. Heine has a Bachelor of Arts degree from Saint Olaf College and a Master of Science degree from the University of Manitoba.


Past Events


Note: Speaker biographies were written at time of speaking engagement and may not reflect their current job title and position.
View All